RZLT · Company research
Rezolute, Inc. Common Stock (NV) (RZLT): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Rezolute (RZLT) Completes Enrollment in Phase 3 Trial for Ersode - GuruFocus | Rezolute (RZLT) Completes Enrollment in Phase 3 Trial for Ersode GuruFocus | View source ↗ | GuruFocus | Oct 14, 2026 | neutral | 0 | 0.6 |
| Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism - Stock Titan | Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| Rezolute Stock Price Forecast. Should You Buy RZLT? - StockInvest.us | Rezolute Stock Price Forecast. Should You Buy RZLT? StockInvest.us | View source ↗ | StockInvest.us | Oct 10, 2026 | neutral | 0 | 0.6 |
| A December 2 shareholder vote could expand Rezolute (RZLT)'s authorized common shares. - Stock Titan | A December 2 shareholder vote could expand Rezolute (RZLT)'s authorized common shares. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| A trial missed key goals, yet FDA recommends a meeting on Rezolute's drug - Stock Titan | A trial missed key goals, yet FDA recommends a meeting on Rezolute's drug Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| RZLT Maintained by HC Wainwright & Co. -- Price Target Raised to $10 - GuruFocus | RZLT Maintained by HC Wainwright & Co. -- Price Target Raised to $10 GuruFocus | View source ↗ | GuruFocus | Sep 25, 2026 | neutral | 0 | 0.6 |
| Seven participants met the main response target in Rezolute's tumor-related low blood sugar study. - Stock Titan | Seven participants met the main response target in Rezolute's tumor-related low blood sugar study. Stock Titan | View source ↗ | Stock Titan | Sep 24, 2026 | neutral | 0 | 0.6 |
| Rezolute Fiscal Q4 Loss Narrows - Yahoo Finance | Rezolute Fiscal Q4 Loss Narrows Yahoo Finance | View source ↗ | Yahoo Finance | Sep 24, 2026 | neutral | 0 | 0.6 |
| Rezolute drops on regulatory update on lead asset (RZLT:NASDAQ) - Seeking Alpha | Rezolute drops on regulatory update on lead asset (RZLT:NASDAQ) Seeking Alpha | View source ↗ | Seeking Alpha | Sep 9, 2026 | neutral | 0 | 0.6 |
| Rezolute, Inc.'s (NASDAQ:RZLT) Shift From Loss To Profit - Simply Wall Street | Rezolute, Inc.'s (NASDAQ:RZLT) Shift From Loss To Profit Simply Wall Street | View source ↗ | Simply Wall Street | Aug 22, 2026 | neutral | 0 | 0.6 |
| $RZLT stock is up 8% today. Here's what we see in our data. - Quiver Quantitative | $RZLT stock is up 8% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 21, 2026 | neutral | 0 | 0.6 |
| $RZLT stock is up 12% today. Here's what we see in our data. - Quiver Quantitative | $RZLT stock is up 12% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 21, 2026 | neutral | 0 | 0.6 |
| RZLT Forecast — Price Target — Prediction for 2027 - TradingView | RZLT Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Guggenheim raises Rezolute stock price target on trial outlook - Investing.com | Guggenheim raises Rezolute stock price target on trial outlook Investing.com | View source ↗ | Investing.com | Jun 15, 2026 | neutral | 0 | 0.6 |
| RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week? - Yahoo Finance | RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 4, 2026 | neutral | 0 | 0.6 |
| $RZLT stock is up 16% today. Here's what we see in our data. - Quiver Quantitative | $RZLT stock is up 16% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 2, 2026 | neutral | 0 | 0.6 |
| Rezolute, Inc. Common Stock (NV) (RZLT) Stock - Gotrade | Rezolute, Inc. Common Stock (NV) (RZLT) Stock Gotrade | View source ↗ | Gotrade | Jan 13, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.